Ikarian Capital’s Avalo Therapeutics AVTX Stock Holding History
Bought
Maintained
Sold
Other funds holding AVTX
Ikarian Capital's AVTX Position: Q3 2026 in Review
Ikarian Capital held its Avalo Therapeutics (AVTX) position steady in Q3 2026 at 90,183 shares worth $1.38M. The position accounts for 0.14% of the portfolio, ranked #116.
Ikarian Capital first reported a position in AVTX in Q4 2019 and has held it in 20 quarters since. The position peaked at $9.22M in Q3 2024. 143 funds tracked by Wall St. Rank hold AVTX as of Q3 2026.
- Ikarian Capital held 90,183 shares of Avalo Therapeutics worth $1.38M as of Q3 2026.
- Ikarian Capital left its Avalo Therapeutics share count unchanged in Q3 2026.
- Avalo Therapeutics made up 0.14% of Ikarian Capital's portfolio in Q3 2026, its #116 holding.
- Ikarian Capital first reported a position in Avalo Therapeutics in Q4 2019 and has held it in 20 quarters since.
- Ikarian Capital's Avalo Therapeutics position peaked at $9.22M in Q3 2024.
- 143 funds tracked by Wall St. Rank held Avalo Therapeutics as of Q3 2026.
Based on Ikarian Capital's 13F filing for Q3 2026, filed 16 Nov 2026.